腦血管支架市場規模、佔有率和成長分析（按材質、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，全球腦血管支架市場規模將達到 4.3 億美元，到 2025 年將達到 4.7 億美元，到 2033 年將達到 8.9 億美元，預測期（2026-2033 年）的複合年成長率為 8.3%。

用於治療腦動脈瘤和維持受損動脈血流的微型網狀管狀器械—腦血管支架的全球市場預計將迎來顯著成長。這一成長主要受腦部疾病發病率上升和人口老化所驅動。醫療技術的進步和生物可吸收支架的日益普及為市場相關人員帶來了新的機會。此外，微創手術的日益普及預計將進一步推動未來對這些支架的需求。然而，高成本以及某些支架相關的手術併發症風險等挑戰可能會阻礙市場發展。儘管如此，越來越多的創新腦部治療方法核准預計將進一步推動腦血管支架的銷售。

全球腦血管支架市場促進因素

全球老年人口的不斷成長顯著推高了腦血管治療的需求。隨著老年人口的增加，與老齡化相關的健康問題也隨之增多，這些問題可能需要進行腦血管支架植入等干涉措施。這一趨勢凸顯了針對老年患者特定需求的先進醫療解決方案的重要性，並最終推動了腦血管支架市場的擴張。因此，醫療服務提供者和製造商必須透過創新和改進治療方案來滿足這一日益成長的需求，從而提高腦血管疾病高風險患者的整體醫療品質。

限制全球腦血管支架市場的因素

由於腦部手術費用高昂，全球腦血管支架市場面臨嚴峻挑戰。這些手術需要先進的醫療技術和經驗豐富的醫護人員，導致病患整體費用增加。因此，腦部手術帶來的經濟負擔成為潛在患者選擇支架植入的障礙，可能對腦血管支架的銷售預測產生不利影響。此外，複雜的手術操作及其高昂的費用也嚴重阻礙因素了市場成長和腦血管治療的可及性。

腦血管支架市場的全球趨勢

全球腦血管支架市場正迅速轉型為生物可吸收支架和藥物釋放型支架等創新解決方案。製造商正優先研發採用生物可吸收材料製成的支架，這些支架在完成其治療任務後可在體內安全溶解，無需後續手術取出。這一趨勢不僅提高了患者的安全性和舒適度，還有助於降低與傳統支架取出手術相關的醫療成本。此外，生物可吸收材料與藥物釋放型功能的融合也在不斷推進，旨在改善治療效果並拓展腦血管疾病的治療選擇。這正在徹底改變整個腦血管介入治療領域。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球腦血管支架市場規模（按材料和複合年成長率分類）（2026-2033 年）

• 鉭
• 不銹鋼
• 鎳鈦諾

全球腦血管支架市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 門診手術中心
• 醫療中心
• 其他

全球腦血管支架市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Medtronic plc（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Stryker Corporation（USA）
• Johnson & Johnson（USA）
• MicroPort Scientific Corporation（China）
• Penumbra, Inc.（USA）
• Asahi Intecc Co., Ltd.（Japan）
• Integer Holdings Corporation（USA）
• B. Braun Melsungen AG（Germany）
• Biotronik SE & Co. KG（Germany）
• Merit Medical Systems, Inc.（USA）
• Kaneka Medix Corp.（Japan）
• Acandis GmbH（Germany）
• Balt（Switzerland）
• Rapid Medical（Israel）
• Medinol Ltd.（Israel）

結論與建議

Global Cerebral Vascular Stent Market size was valued at USD 0.43 Billion in 2024 and is poised to grow from USD 0.47 Billion in 2025 to USD 0.89 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The global market for cerebral vascular stents, small mesh-like tubes used to treat brain aneurysms and maintain blood flow in compromised arteries, is poised for significant growth. This expansion is primarily driven by the rising prevalence of cerebral disorders and an aging population. Healthcare advancements and the increasing adoption of bioabsorbable stents present new opportunities for market players. Additionally, the trend towards minimally invasive surgeries stands to elevate the demand for these stents over time. However, challenges such as the high costs associated with certain stents and the risk of procedural complications may hinder market progress. On a positive note, the growing number of approvals for innovative cerebral treatment methods is expected to further enhance sales of cerebral vascular stents.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cerebral Vascular Stent market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cerebral Vascular Stent Market Segments Analysis

Global Cerebral Vascular Stent Market is segmented by Material, End User and region. Based on Material, the market is segmented into Tantalum, Stainless Steel and Nitinol. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Medical Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cerebral Vascular Stent Market

The rising global population of older individuals significantly contributes to an increased demand for cerebral and vascular treatments. As this demographic grows, the likelihood of age-related health issues, including those requiring interventions like cerebral vascular stenting, becomes more pronounced. This trend highlights the importance of advanced medical solutions to address the specific needs of aging patients, ultimately driving the expansion of the cerebral vascular stent market. Consequently, healthcare providers and manufacturers are compelled to respond to this growing demand by innovating and improving treatment options, thereby enhancing the overall quality of care for patients at risk of cerebral vascular conditions.

Restraints in the Global Cerebral Vascular Stent Market

The global market for cerebral vascular stents faces significant challenges due to the high expenses associated with brain-related surgeries. These procedures demand advanced medical technologies and require highly skilled healthcare professionals, leading to increased overall costs for patients. As a result, the financial burden associated with cerebral procedures may deter potential patients from opting for stent placements, thereby negatively influencing the sales forecast for cerebral vascular stents. The combination of intricate medical interventions and their associated high costs poses a considerable restraint on market growth and accessibility for those in need of cerebral vascular solutions.

Market Trends of the Global Cerebral Vascular Stent Market

The Global Cerebral Vascular Stent market is increasingly gravitating towards innovative solutions such as bioabsorbable stents and drug-eluting stent technologies. Manufacturers are prioritizing the development of stents crafted from bioabsorbable materials, which eliminate the need for subsequent surgical extraction by safely dissolving in the body after fulfilling their purpose. This trend not only enhances patient safety and comfort but also reduces healthcare costs associated with traditional stent removal procedures. Additionally, the integration of drug-eluting functionalities with bioabsorbable materials is gaining momentum, aimed at improving therapeutic outcomes and expanding treatment options for cerebrovascular conditions, thereby transforming the landscape of cerebral vascular interventions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cerebral Vascular Stent Market Size by Material & CAGR (2026-2033)

• Market Overview
• Tantalum
• Stainless Steel
• Nitinol

Global Cerebral Vascular Stent Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Medical Centres
• Others

Global Cerebral Vascular Stent Market Size & CAGR (2026-2033)

• North America (Material, End User)
  • US
  • Canada
• Europe (Material, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Medix Corp. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medinol Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations